Summary: "The vector of anti-PSMA chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human PSMA. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-PSMA antibody linked to a CD28 transmembrane domain/ endodomain and OX40, CD3-zeta signaling domains. And the vector product was designed for the treatment of prostate cancer, ALS, and other neurodegenerative diseases such as Park. https://www.creative-biolabs.com/car-t/pcdcar1-psma-h-28ox%CE%B6-t-502.htm"